vs

Side-by-side financial comparison of FULLER H B CO (FUL) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.

OPEN TEXT CORP is the larger business by last-quarter revenue ($1.3B vs $892.0M, roughly 1.5× FULLER H B CO). OPEN TEXT CORP runs the higher net margin — 12.7% vs 7.5%, a 5.1% gap on every dollar of revenue. On growth, OPEN TEXT CORP posted the faster year-over-year revenue change (-0.6% vs -2.8%). OPEN TEXT CORP produced more free cash flow last quarter ($279.4M vs $68.9M). Over the past eight quarters, FULLER H B CO's revenue compounded faster (5.0% CAGR vs -4.3%).

H.B. Fuller Company is an American multinational adhesives manufacturing company headquartered in St. Paul, Minnesota. H.B. Fuller manufactures more than 20,000 products for a variety of applications, including those used in construction, engineering, electronics, hygiene products, and food packaging. Its products are made at 81 manufacturing facilities in 26 countries. As of 2024, it was the fourth-largest manufacturer of adhesives and sealants in the world, employed approximately 7,500 peop...

Open Text Corporation is a global software company that develops and sells information management software.

FUL vs OTEX — Head-to-Head

Bigger by revenue
OTEX
OTEX
1.5× larger
OTEX
$1.3B
$892.0M
FUL
Growing faster (revenue YoY)
OTEX
OTEX
+2.2% gap
OTEX
-0.6%
-2.8%
FUL
Higher net margin
OTEX
OTEX
5.1% more per $
OTEX
12.7%
7.5%
FUL
More free cash flow
OTEX
OTEX
$210.5M more FCF
OTEX
$279.4M
$68.9M
FUL
Faster 2-yr revenue CAGR
FUL
FUL
Annualised
FUL
5.0%
-4.3%
OTEX

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
FUL
FUL
OTEX
OTEX
Revenue
$892.0M
$1.3B
Net Profit
$67.2M
$168.1M
Gross Margin
32.0%
74.0%
Operating Margin
12.3%
22.0%
Net Margin
7.5%
12.7%
Revenue YoY
-2.8%
-0.6%
Net Profit YoY
21.3%
-26.9%
EPS (diluted)
$1.22
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUL
FUL
OTEX
OTEX
Q4 25
$1.3B
Q3 25
$892.0M
$1.3B
Q2 25
$898.1M
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$917.9M
$1.3B
Q2 24
$1.4B
Q1 24
$810.4M
$1.4B
Net Profit
FUL
FUL
OTEX
OTEX
Q4 25
$168.1M
Q3 25
$67.2M
$146.6M
Q2 25
$41.8M
$28.8M
Q1 25
$92.8M
Q4 24
$229.9M
Q3 24
$55.4M
$84.4M
Q2 24
$248.2M
Q1 24
$31.0M
$98.3M
Gross Margin
FUL
FUL
OTEX
OTEX
Q4 25
74.0%
Q3 25
32.0%
72.8%
Q2 25
31.9%
72.3%
Q1 25
71.6%
Q4 24
73.3%
Q3 24
30.0%
71.7%
Q2 24
72.5%
Q1 24
29.5%
73.0%
Operating Margin
FUL
FUL
OTEX
OTEX
Q4 25
22.0%
Q3 25
12.3%
21.0%
Q2 25
11.1%
13.9%
Q1 25
16.7%
Q4 24
22.2%
Q3 24
11.4%
16.3%
Q2 24
14.2%
Q1 24
8.3%
15.7%
Net Margin
FUL
FUL
OTEX
OTEX
Q4 25
12.7%
Q3 25
7.5%
11.4%
Q2 25
4.7%
2.2%
Q1 25
7.4%
Q4 24
17.2%
Q3 24
6.0%
6.6%
Q2 24
18.2%
Q1 24
3.8%
6.8%
EPS (diluted)
FUL
FUL
OTEX
OTEX
Q4 25
$0.66
Q3 25
$1.22
$0.58
Q2 25
$0.76
$0.11
Q1 25
$0.35
Q4 24
$0.87
Q3 24
$0.98
$0.32
Q2 24
$0.91
Q1 24
$0.55
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUL
FUL
OTEX
OTEX
Cash + ST InvestmentsLiquidity on hand
$122.5M
$1.3B
Total DebtLower is stronger
$6.4B
Stockholders' EquityBook value
$2.0B
$4.0B
Total Assets
$5.2B
$13.6B
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUL
FUL
OTEX
OTEX
Q4 25
$1.3B
Q3 25
$122.5M
$1.1B
Q2 25
$96.8M
$1.2B
Q1 25
$1.3B
Q4 24
$1.1B
Q3 24
$131.4M
$1.0B
Q2 24
$1.3B
Q1 24
$165.2M
$1.1B
Total Debt
FUL
FUL
OTEX
OTEX
Q4 25
$6.4B
Q3 25
$6.4B
Q2 25
$6.4B
Q1 25
$6.4B
Q4 24
$6.4B
Q3 24
$6.4B
Q2 24
$6.4B
Q1 24
$8.4B
Stockholders' Equity
FUL
FUL
OTEX
OTEX
Q4 25
$4.0B
Q3 25
$2.0B
$4.0B
Q2 25
$1.9B
$3.9B
Q1 25
$4.1B
Q4 24
$4.2B
Q3 24
$1.8B
$4.1B
Q2 24
$4.2B
Q1 24
$1.8B
$4.1B
Total Assets
FUL
FUL
OTEX
OTEX
Q4 25
$13.6B
Q3 25
$5.2B
$13.5B
Q2 25
$5.1B
$13.8B
Q1 25
$13.8B
Q4 24
$13.7B
Q3 24
$5.0B
$13.8B
Q2 24
$14.2B
Q1 24
$4.7B
$16.4B
Debt / Equity
FUL
FUL
OTEX
OTEX
Q4 25
1.58×
Q3 25
1.61×
Q2 25
1.62×
Q1 25
1.55×
Q4 24
1.51×
Q3 24
1.55×
Q2 24
1.52×
Q1 24
2.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUL
FUL
OTEX
OTEX
Operating Cash FlowLast quarter
$99.0M
$318.7M
Free Cash FlowOCF − Capex
$68.9M
$279.4M
FCF MarginFCF / Revenue
7.7%
21.1%
Capex IntensityCapex / Revenue
3.4%
3.0%
Cash ConversionOCF / Net Profit
1.47×
1.90×
TTM Free Cash FlowTrailing 4 quarters
$878.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUL
FUL
OTEX
OTEX
Q4 25
$318.7M
Q3 25
$99.0M
$147.8M
Q2 25
$158.2M
Q1 25
$402.2M
Q4 24
$348.0M
Q3 24
$169.4M
$-77.8M
Q2 24
$185.2M
Q1 24
$47.4M
$384.7M
Free Cash Flow
FUL
FUL
OTEX
OTEX
Q4 25
$279.4M
Q3 25
$68.9M
$101.2M
Q2 25
$124.0M
Q1 25
$373.8M
Q4 24
$306.7M
Q3 24
$99.9M
$-117.1M
Q2 24
$145.2M
Q1 24
$4.1M
$348.2M
FCF Margin
FUL
FUL
OTEX
OTEX
Q4 25
21.1%
Q3 25
7.7%
7.9%
Q2 25
9.5%
Q1 25
29.8%
Q4 24
23.0%
Q3 24
10.9%
-9.2%
Q2 24
10.7%
Q1 24
0.5%
24.1%
Capex Intensity
FUL
FUL
OTEX
OTEX
Q4 25
3.0%
Q3 25
3.4%
3.6%
Q2 25
2.6%
Q1 25
2.3%
Q4 24
3.1%
Q3 24
7.6%
3.1%
Q2 24
2.9%
Q1 24
5.3%
2.5%
Cash Conversion
FUL
FUL
OTEX
OTEX
Q4 25
1.90×
Q3 25
1.47×
1.01×
Q2 25
5.49×
Q1 25
4.33×
Q4 24
1.51×
Q3 24
3.06×
-0.92×
Q2 24
0.75×
Q1 24
1.53×
3.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FUL
FUL

Hygiene Health And Consumable Adhesives$386.1M43%
Engineering Adhesives$272.3M31%
Building Adhesives Solutions$233.7M26%

OTEX
OTEX

Transferred At Point In Time$184.2M14%
Cybersecurity Enterprise Product$174.5M13%
Business Network Product$159.8M12%
Business Network Cloud Services And Subscriptions$151.4M11%
Content Cloud Services And Subscriptions$137.9M10%
Cybersecurity SMB Consumer Product$127.6M10%
Application Delivery Management Product$120.1M9%
IT Operations Management Product$113.3M9%
Professional Service And Other$82.5M6%
Analytics Product$58.1M4%
IT Operations Management Cloud Services And Subscriptions$7.8M1%

Related Comparisons